data_1f7w_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1f7w _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.427 ' C ' ' H ' ' A' ' 3' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 109.568 -0.53 . . . . 9.4000000000000004 109.568 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.65 ' N ' ' HZ3' ' A' ' 3' ' ' LYS . 58.6 m-20 -78.91 7.46 7.13 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.652 -1.24 . . . . 6.9199999999999999 107.652 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.65 ' HZ3' ' N ' ' A' ' 2' ' ' ASP . 0.0 OUTLIER -120.4 82.07 31.51 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 106.398 -1.704 . . . . 7.6399999999999997 106.398 177.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.586 ' C ' ' H ' ' A' ' 6' ' ' ARG . 1.9 Cg_endo -64.53 69.15 0.24 Allowed 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 120.895 1.063 . . . . 4.8300000000000001 113.438 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 3' ' ' LYS . 32.3 mttt -68.93 11.96 0.17 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.566 -1.334 . . . . 4.2800000000000002 108.333 178.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.586 ' H ' ' C ' ' A' ' 4' ' ' PRO . 61.6 mtt180 -86.76 141.04 29.15 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.728 -0.841 . . . . 3.6499999999999999 108.728 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -84.44 -0.4 52.7 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.142 -1.059 . . . . 2.6800000000000002 108.142 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -153.65 142.99 21.55 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.081 -1.081 . . . . 2.0499999999999998 108.081 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -161.98 -174.93 4.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.944 -1.098 . . . . 1.1200000000000001 109.946 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 91.7 t -137.95 133.96 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.787 -0.57 . . . . 1.2 109.468 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.4 mm -88.98 132.27 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 107.351 -1.351 . . . . 1.1100000000000001 107.351 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.425 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.4 mt -124.05 150.39 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 121.903 0.859 . . . . 1.1499999999999999 110.586 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.459 ' N ' ' O ' ' A' ' 84' ' ' ILE . 37.2 mtt -149.76 157.06 42.85 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.536 -1.283 . . . . 1.26 107.536 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -139.98 121.37 15.02 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.25 -0.907 . . . . 1.8700000000000001 111.466 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.9 t -104.28 112.35 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.113 -1.069 . . . . 1.0800000000000001 108.113 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -143.6 156.83 44.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.635 -0.665 . . . . 1.04 109.923 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.69 -168.91 0.77 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.475 -0.766 . . . . 1.0800000000000001 109.557 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -61.46 164.91 5.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 2.2000000000000002 109.43 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.3 m80 -66.43 146.99 53.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.227 -0.921 . . . . 3.79 109.676 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.01 9.95 86.12 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.711 -1.356 . . . . 0.63 109.711 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 63.0 m -128.55 144.77 51.21 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.908 -0.76 . . . . 1.01 109.165 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -127.51 145.87 50.7 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.395 0.617 . . . . 1.6299999999999999 109.374 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 64.2 mt -85.27 144.35 28.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.337 -0.852 . . . . 1.1100000000000001 109.373 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -68.07 143.18 55.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.225 -0.922 . . . . 1.79 109.153 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.63 -40.0 95.86 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.615 -1.394 . . . . 0.23999999999999999 109.615 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -62.62 -53.93 47.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.074 -1.25 . . . . 1.79 109.862 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 65.7 mt -63.49 -22.36 66.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.893 . . . . 1.0900000000000001 109.081 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.415 ' CD2' ' C ' ' A' ' 28' ' ' LEU . 6.2 tt -75.92 -58.46 3.27 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.439 -0.788 . . . . 1.1200000000000001 109.066 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.3 mt -60.14 -40.06 88.49 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.275 -0.891 . . . . 1.1799999999999999 110.436 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -62.63 -42.98 99.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.011 -1.056 . . . . 2.5499999999999998 109.741 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.459 ' HG ' ' CG2' ' A' ' 108' ' ' ILE . 1.7 p -64.25 -38.89 92.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.2 -0.938 . . . . 1.9199999999999999 109.775 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.5 mt -60.04 -48.82 86.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.877 -1.139 . . . . 1.1200000000000001 108.749 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -65.03 -41.31 95.37 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.113 -0.992 . . . . 2.7799999999999998 109.997 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -67.71 -15.0 63.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.144 -0.972 . . . . 2.4900000000000002 109.697 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.536 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -83.4 -7.84 59.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.064 -1.022 . . . . 1.1200000000000001 109.75 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.66 10.36 55.51 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 110.23 -1.148 . . . . 0.40999999999999998 110.23 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -80.49 156.22 26.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.132 -1.216 . . . . 0.80000000000000004 109.726 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 86.5 mt -125.74 136.68 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.907 -0.775 . . . . 1.1100000000000001 108.907 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -59.99 103.83 0.25 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.073 -1.017 . . . . 0.42999999999999999 109.485 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.31 171.05 34.8 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.337 -1.105 . . . . 0.37 110.337 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -64.54 -162.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.591 -0.946 . . . . 1.22 108.929 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 54.81 21.3 3.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.444 -0.785 . . . . 2.71 109.158 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.5 m120 50.42 41.4 24.85 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.545 -0.722 . . . . 1.96 111.164 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.8 pt -142.06 164.39 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.16 -0.962 . . . . 1.1100000000000001 108.861 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -91.6 122.27 34.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.125 -0.985 . . . . 0.98999999999999999 110.399 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.551 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 13.8 m-70 -111.49 129.03 56.17 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.565 -0.532 . . . . 2.1400000000000001 109.565 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.536 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 56.2 ttt180 -104.59 128.13 52.5 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.133 -0.692 . . . . 2.5299999999999998 109.133 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.45 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 41.6 m-70 -97.61 171.23 8.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.581 -0.699 . . . . 0.46000000000000002 109.535 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 62.1 tp -55.6 -50.38 70.29 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.311 -0.868 . . . . 1.1699999999999999 109.025 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.1 m -92.56 145.5 30.59 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.421 -0.799 . . . . 1.1100000000000001 109.507 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -66.44 -5.8 13.63 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 CA-C-N 119.929 1.01 . . . . 0.73999999999999999 112.689 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -91.47 -0.01 57.57 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.098 -1.001 . . . . 2.1899999999999999 109.896 -179.148 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.92 13.67 82.32 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.706 -1.358 . . . . 0.41999999999999998 109.706 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.9 p -72.56 -45.36 59.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.153 -1.204 . . . . 1.95 110.384 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.45 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -75.98 170.07 54.75 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.706 -1.358 . . . . 0.39000000000000001 109.706 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -67.88 174.21 8.06 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.067 1.178 . . . . 0.45000000000000001 112.416 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.62 122.68 28.92 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.214 -0.928 . . . . 1.1299999999999999 109.097 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.535 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 6.5 mp -96.78 -42.49 7.96 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.276 -0.89 . . . . 1.1599999999999999 109.373 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -145.49 170.34 16.59 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.027 -1.046 . . . . 0.41999999999999998 108.531 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.551 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 1.6 m -138.91 179.9 6.22 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.721 -0.792 . . . . 1.05 110.738 -177.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.432 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 6.3 tt -136.57 129.97 31.67 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.914 -0.773 . . . . 1.0700000000000001 108.914 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 83' ' ' THR . . . -129.13 158.48 38.84 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.3 -0.63 . . . . 1.0800000000000001 109.3 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.413 ' ND2' ' CE2' ' A' ' 70' ' ' PHE . 64.8 m-20 -75.62 158.46 32.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 2.0 109.679 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 90.6 mtp -69.99 -23.02 63.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.396 -0.815 . . . . 1.51 109.831 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.69 127.53 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.066 -1.021 . . . . 2.04 109.169 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -65.98 150.25 96.79 Favored Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.011 -1.055 . . . . 2.9399999999999999 109.036 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -76.32 -1.51 22.98 Favored 'Cis proline' 0 N--CA 1.499 1.838 0 C-N-CA 124.196 -1.168 . . . . 1.0900000000000001 112.994 -0.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.46 16.04 55.95 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.832 -1.175 . . . . 0.47999999999999998 110.233 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.4 p -90.66 167.99 12.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.153 -1.204 . . . . 1.27 110.066 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.413 ' CE2' ' ND2' ' A' ' 63' ' ' ASN . 46.3 m-85 -116.53 157.04 25.88 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.395 -0.965 . . . . 0.64000000000000001 108.395 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.418 ' H ' ' HG3' ' A' ' 74' ' ' MET . 8.7 m-20 -140.36 152.12 65.94 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 109.053 -0.721 . . . . 1.8899999999999999 109.053 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -57.63 -15.66 21.46 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 120.69 0.927 . . . . 0.93999999999999995 113.057 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -88.21 8.62 26.27 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.099 -1.0 . . . . 2.2400000000000002 109.761 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.418 ' HG3' ' H ' ' A' ' 71' ' ' ASP . 1.2 mtm -91.78 22.67 4.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.394 -0.816 . . . . 3.9199999999999999 110.108 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.412 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 13.2 mttm -83.41 -1.56 53.76 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.031 -1.043 . . . . 2.3300000000000001 108.633 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 72.5 m-20 -152.59 73.41 1.02 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.385 -0.822 . . . . 1.4299999999999999 109.364 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -150.21 171.51 16.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.123 -0.986 . . . . 0.48999999999999999 109.007 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 81.4 p -130.28 152.5 49.63 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.223 -0.658 . . . . 1.1799999999999999 109.223 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.34 149.68 22.02 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.194 -0.941 . . . . 1.0 108.998 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -50.4 -35.99 46.64 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 CA-C-N 119.453 0.84 . . . . 0.41999999999999998 112.232 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 173.39 -151.76 14.24 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.431 -1.468 . . . . 0.28999999999999998 109.431 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.6 m -130.57 163.93 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.924 -0.75 . . . . 1.1000000000000001 109.776 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 62' ' ' ALA . 19.2 m -117.35 119.38 34.95 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.068 0.461 . . . . 1.0800000000000001 110.116 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.459 ' O ' ' N ' ' A' ' 13' ' ' MET . 76.0 mt -104.24 132.96 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.202 -1.036 . . . . 1.0600000000000001 108.202 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -147.07 166.48 26.75 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.767 -0.773 . . . . 0.48999999999999999 110.023 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 5.4 ttp -133.06 128.52 36.43 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.175 -0.676 . . . . 2.3700000000000001 109.175 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -88.01 109.93 20.21 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.156 -0.965 . . . . 2.2999999999999998 108.852 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.7 m -98.8 149.24 35.56 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 108.571 -0.9 . . . . 1.6499999999999999 108.571 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -72.38 133.5 29.9 Favored 'Cis proline' 0 N--CA 1.501 1.93 0 CA-C-N 120.161 1.093 . . . . 0.91000000000000003 113.514 0.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 62.8 m -106.7 159.99 15.8 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.566 0.698 . . . . 1.05 110.109 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -72.4 149.19 44.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.519 -0.738 . . . . 1.0900000000000001 109.705 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.5 -160.14 32.71 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.699 -1.36 . . . . 0.5 109.699 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -95.21 110.46 22.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.464 -1.021 . . . . 2.0299999999999998 109.013 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -54.66 -27.38 39.59 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.351 -0.843 . . . . 2.02 109.107 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.47 -40.33 73.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.101 -0.999 . . . . 1.23 109.567 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -72.81 -40.01 66.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.953 -1.092 . . . . 2.6200000000000001 108.844 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -61.15 -39.91 91.85 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.89 -0.782 . . . . 2.0 108.89 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -54.64 -42.83 71.74 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.988 -0.745 . . . . 0.44 108.988 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -64.5 -39.67 94.22 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.391 -0.818 . . . . 2.5 109.142 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 20.5 mt -59.9 -45.09 93.64 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.185 -0.947 . . . . 2.0699999999999998 109.464 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 96.2 mtp -55.33 -49.93 70.94 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.316 -0.865 . . . . 1.1200000000000001 108.783 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 32.3 mt -62.94 -46.67 86.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.311 -0.868 . . . . 1.0900000000000001 110.07 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.518 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 94.0 mt-30 -59.11 -39.94 83.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.13 -0.982 . . . . 2.2999999999999998 108.771 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.3 p -71.76 -39.99 69.6 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.138 -0.977 . . . . 0.96999999999999997 109.523 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.0 -56.37 23.1 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.233 -0.917 . . . . 1.1000000000000001 110.124 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -60.01 -38.14 81.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 1.79 109.349 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.518 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 6.9 m-70 -59.95 -48.88 79.88 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.126 -0.984 . . . . 0.60999999999999999 109.119 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.459 ' CG2' ' HG ' ' A' ' 31' ' ' SER . 77.0 mt -60.59 -49.99 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 1.1499999999999999 109.274 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.4 -47.11 63.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.492 -0.755 . . . . 1.02 109.078 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -61.94 -40.04 94.17 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.414 -0.804 . . . . 1.23 110.161 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -69.97 -40.45 75.37 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.992 -1.068 . . . . 1.8899999999999999 110.983 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.8 m -101.46 7.64 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.505 -0.747 . . . . 1.1000000000000001 109.472 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 61.53 25.54 65.35 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.42 -1.472 . . . . 0.40000000000000002 109.42 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.54 -175.05 50.64 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.617 -1.393 . . . . 0.32000000000000001 109.617 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 38.6 t -130.07 138.86 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.816 -0.814 . . . . 1.3100000000000001 109.256 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 22.0 t -76.71 133.31 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.19 -0.944 . . . . 1.1299999999999999 109.589 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 39.7 mt -133.28 162.05 32.84 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.451 0.643 . . . . 1.0700000000000001 109.548 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -89.94 -168.95 2.28 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.513 -0.742 . . . . 1.1299999999999999 109.849 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.504 ' CG ' ' HH ' ' A' ' 132' ' ' TYR . 88.7 m-20 -59.99 -36.56 77.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.454 -0.779 . . . . 1.1200000000000001 109.146 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -81.14 20.58 0.8 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 2.1099999999999999 109.137 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.428 ' H ' ' C ' ' A' ' 119' ' ' ASP . 33.1 mtt180 52.27 30.5 8.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.513 -0.742 . . . . 3.4500000000000002 110.108 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 -107.87 154.84 20.99 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.697 -0.627 . . . . 3.6600000000000001 109.502 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 91.0 mtp -51.5 121.88 7.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 2.52 109.113 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 17.9 mtp -57.54 137.4 56.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.234 -0.916 . . . . 1.45 109.336 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.9 p -129.95 152.94 80.8 Favored Pre-proline 0 N--CA 1.497 1.888 0 N-CA-C 109.263 -0.643 . . . . 1.27 109.263 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -46.19 -43.58 20.76 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 120.855 1.037 . . . . 0.62 113.204 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.13 -40.7 90.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.076 -1.015 . . . . 2.1499999999999999 110.08 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -69.35 -37.1 77.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.051 -1.031 . . . . 2.27 109.686 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 97.5 mt -56.4 -40.07 74.05 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.095 -1.076 . . . . 1.25 108.095 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 13.7 mtt-85 -64.67 -38.96 92.8 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.378 -0.827 . . . . 4.3700000000000001 109.592 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -59.98 -46.83 88.16 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.114 -0.992 . . . . 1.98 109.446 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.504 ' HH ' ' CG ' ' A' ' 119' ' ' ASP . 60.3 m-85 -60.63 -45.8 92.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.074 -1.016 . . . . 0.91000000000000003 109.695 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -60.11 -36.51 77.63 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.347 -0.846 . . . . 1.9399999999999999 109.108 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.73 -40.06 93.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.201 -0.937 . . . . 1.2 109.721 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 56.8 mt -60.94 -41.41 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.072 -1.017 . . . . 1.3799999999999999 108.794 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.7 mt -61.18 -44.38 98.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.338 -0.851 . . . . 1.1000000000000001 109.622 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -61.94 -48.52 80.04 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.192 -0.943 . . . . 3.5600000000000001 111.508 -178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.441 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 4.6 mt-10 -60.02 -27.97 67.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.832 -1.168 . . . . 2.29 109.488 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 74.5 t -77.89 -28.21 15.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 120.918 -1.114 . . . . 1.46 109.333 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.422 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 28.4 mttm -63.84 -44.87 91.91 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.742 -1.223 . . . . 2.0299999999999998 110.675 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 141' ' ' ASP . 1.1 p-10 -62.97 -24.0 67.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.069 -1.019 . . . . 1.3999999999999999 109.867 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.36 -34.96 77.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.05 -1.031 . . . . 1.3700000000000001 108.964 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.513 ' OD1' ' N ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER -107.01 -34.29 7.23 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.615 -0.513 . . . . 3.0899999999999999 109.615 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.01 -0.995 . . . . 2.4500000000000002 109.426 179.89 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 109.568 -0.53 . . . . 9.0 109.568 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.733 ' N ' ' HZ2' ' A' ' 3' ' ' LYS . 58.6 m-20 -78.91 7.46 7.13 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.652 -1.24 . . . . 6.9199999999999999 107.652 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.733 ' HZ2' ' N ' ' A' ' 2' ' ' ASP . 0.0 OUTLIER -120.4 82.07 31.51 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 106.398 -1.704 . . . . 7.3700000000000001 106.398 177.904 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.549 ' C ' ' H ' ' A' ' 6' ' ' ARG . 1.9 Cg_endo -64.53 69.15 0.24 Allowed 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 120.895 1.063 . . . . 4.2599999999999998 113.438 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 3' ' ' LYS . 32.3 mttt -68.93 11.96 0.17 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.566 -1.334 . . . . 3.8999999999999999 108.333 178.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.549 ' H ' ' C ' ' A' ' 4' ' ' PRO . 61.6 mtt180 -86.76 141.04 29.15 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.728 -0.841 . . . . 3.1200000000000001 108.728 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -84.44 -0.4 52.7 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.142 -1.059 . . . . 2.2400000000000002 108.142 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -153.65 142.99 21.55 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.081 -1.081 . . . . 2.0499999999999998 108.081 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -161.98 -174.93 4.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.944 -1.098 . . . . 0.46999999999999997 109.946 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 91.7 t -137.95 133.96 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.787 -0.57 . . . . 0.5 109.468 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.4 mm -88.98 132.27 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 107.351 -1.351 . . . . 0.32000000000000001 107.351 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.425 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.4 mt -124.05 150.39 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 121.903 0.859 . . . . 0.33000000000000002 110.586 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.459 ' N ' ' O ' ' A' ' 84' ' ' ILE . 37.2 mtt -149.76 157.06 42.85 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.536 -1.283 . . . . 0.54000000000000004 107.536 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -139.98 121.37 15.02 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.25 -0.907 . . . . 1.0900000000000001 111.466 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.9 t -104.28 112.35 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.113 -1.069 . . . . 0.27000000000000002 108.113 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -143.6 156.83 44.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.635 -0.665 . . . . 0.31 109.923 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.47 ' HB2' HD21 ' A' ' 23' ' ' LEU . . . -74.69 -168.91 0.77 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.475 -0.766 . . . . 0.34999999999999998 109.557 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -61.46 164.91 5.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 1.3700000000000001 109.43 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.3 m80 -66.43 146.99 53.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.227 -0.921 . . . . 2.9500000000000002 109.676 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.01 9.95 86.12 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.711 -1.356 . . . . 0.56000000000000005 109.711 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 63.0 m -128.55 144.77 51.21 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.908 -0.76 . . . . 0.45000000000000001 109.165 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -127.51 145.87 50.7 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.395 0.617 . . . . 1.6299999999999999 109.374 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.47 HD21 ' HB2' ' A' ' 17' ' ' ALA . 64.2 mt -85.27 144.35 28.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.337 -0.852 . . . . 0.31 109.373 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -68.07 143.18 55.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.225 -0.922 . . . . 1.0700000000000001 109.153 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.63 -40.0 95.86 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.615 -1.394 . . . . 0.22 109.615 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -62.62 -53.93 47.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.074 -1.25 . . . . 1.79 109.862 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 65.7 mt -63.49 -22.36 66.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.893 . . . . 0.31 109.081 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.613 ' C ' HD23 ' A' ' 28' ' ' LEU . 6.2 tt -75.92 -58.46 3.27 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.439 -0.788 . . . . 0.38 109.066 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.3 mt -60.14 -40.06 88.49 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.275 -0.891 . . . . 0.45000000000000001 110.436 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -62.63 -42.98 99.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.011 -1.056 . . . . 2.21 109.741 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.471 ' OG ' HG23 ' A' ' 108' ' ' ILE . 1.7 p -64.25 -38.89 92.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.2 -0.938 . . . . 1.3700000000000001 109.775 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.5 mt -60.04 -48.82 86.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.877 -1.139 . . . . 0.38 108.749 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -65.03 -41.31 95.37 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.113 -0.992 . . . . 2.1099999999999999 109.997 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -67.71 -15.0 63.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.144 -0.972 . . . . 1.9099999999999999 109.697 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.536 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -83.4 -7.84 59.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.064 -1.022 . . . . 0.44 109.75 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.66 10.36 55.51 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 110.23 -1.148 . . . . 0.35999999999999999 110.23 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -80.49 156.22 26.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.132 -1.216 . . . . 0.57999999999999996 109.726 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 86.5 mt -125.74 136.68 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.907 -0.775 . . . . 0.35999999999999999 108.907 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -59.99 103.83 0.25 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.073 -1.017 . . . . 0.38 109.485 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.31 171.05 34.8 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.337 -1.105 . . . . 0.29999999999999999 110.337 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -64.54 -162.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.591 -0.946 . . . . 1.22 108.929 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 54.81 21.3 3.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.444 -0.785 . . . . 2.1499999999999999 109.158 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.5 m120 50.42 41.4 24.85 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.545 -0.722 . . . . 1.2 111.164 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.8 pt -142.06 164.39 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.16 -0.962 . . . . 0.33000000000000002 108.861 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -91.6 122.27 34.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.125 -0.985 . . . . 0.33000000000000002 110.399 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.519 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 13.8 m-70 -111.49 129.03 56.17 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.565 -0.532 . . . . 1.1399999999999999 109.565 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.536 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 56.2 ttt180 -104.59 128.13 52.5 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.133 -0.692 . . . . 2.0699999999999998 109.133 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.45 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 41.6 m-70 -97.61 171.23 8.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.581 -0.699 . . . . 0.38 109.535 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 62.1 tp -55.6 -50.38 70.29 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.311 -0.868 . . . . 0.54000000000000004 109.025 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.1 m -92.56 145.5 30.59 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.421 -0.799 . . . . 0.60999999999999999 109.507 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -66.44 -5.8 13.63 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 CA-C-N 119.929 1.01 . . . . 0.68000000000000005 112.689 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -91.47 -0.01 57.57 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.098 -1.001 . . . . 2.1899999999999999 109.896 -179.148 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.92 13.67 82.32 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.706 -1.358 . . . . 0.41999999999999998 109.706 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.9 p -72.56 -45.36 59.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.153 -1.204 . . . . 1.4299999999999999 110.384 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.45 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -75.98 170.07 54.75 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.706 -1.358 . . . . 0.37 109.706 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -67.88 174.21 8.06 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.067 1.178 . . . . 0.40999999999999998 112.416 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.457 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -83.62 122.68 28.92 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.214 -0.928 . . . . 0.38 109.097 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.701 ' N ' HD12 ' A' ' 58' ' ' LEU . 6.5 mp -96.78 -42.49 7.96 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.276 -0.89 . . . . 0.53000000000000003 109.373 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -145.49 170.34 16.59 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.027 -1.046 . . . . 0.37 108.531 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.519 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 1.6 m -138.91 179.9 6.22 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.721 -0.792 . . . . 0.53000000000000003 110.738 -177.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.684 HD23 ' C ' ' A' ' 61' ' ' LEU . 6.3 tt -136.57 129.97 31.67 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.914 -0.773 . . . . 0.29999999999999999 108.914 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.565 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -129.13 158.48 38.84 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.3 -0.63 . . . . 0.28000000000000003 109.3 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.413 ' ND2' ' CE2' ' A' ' 70' ' ' PHE . 64.8 m-20 -75.62 158.46 32.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 1.2 109.679 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 90.6 mtp -69.99 -23.02 63.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.396 -0.815 . . . . 1.1699999999999999 109.831 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.69 127.53 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.066 -1.021 . . . . 1.3899999999999999 109.169 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -65.98 150.25 96.79 Favored Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.011 -1.055 . . . . 2.52 109.036 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -76.32 -1.51 22.98 Favored 'Cis proline' 0 N--CA 1.499 1.838 0 C-N-CA 124.196 -1.168 . . . . 0.87 112.994 -0.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.46 16.04 55.95 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.832 -1.175 . . . . 0.47999999999999998 110.233 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.4 p -90.66 167.99 12.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.153 -1.204 . . . . 0.63 110.066 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.413 ' CE2' ' ND2' ' A' ' 63' ' ' ASN . 46.3 m-85 -116.53 157.04 25.88 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.395 -0.965 . . . . 0.51000000000000001 108.395 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.498 ' H ' ' HG3' ' A' ' 74' ' ' MET . 8.7 m-20 -140.36 152.12 65.94 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 109.053 -0.721 . . . . 1.8899999999999999 109.053 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -57.63 -15.66 21.46 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 120.69 0.927 . . . . 0.82999999999999996 113.057 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -88.21 8.62 26.27 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.099 -1.0 . . . . 2.2400000000000002 109.761 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.498 ' HG3' ' H ' ' A' ' 71' ' ' ASP . 1.2 mtm -91.78 22.67 4.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.394 -0.816 . . . . 3.5 110.108 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.412 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 13.2 mttm -83.41 -1.56 53.76 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.031 -1.043 . . . . 1.8200000000000001 108.633 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 72.5 m-20 -152.59 73.41 1.02 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.385 -0.822 . . . . 1.4299999999999999 109.364 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -150.21 171.51 16.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.123 -0.986 . . . . 0.42999999999999999 109.007 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 81.4 p -130.28 152.5 49.63 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.223 -0.658 . . . . 0.44 109.223 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.34 149.68 22.02 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.194 -0.941 . . . . 0.22 108.998 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -50.4 -35.99 46.64 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 CA-C-N 119.453 0.84 . . . . 0.29999999999999999 112.232 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 173.39 -151.76 14.24 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.431 -1.468 . . . . 0.23000000000000001 109.431 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.6 m -130.57 163.93 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.924 -0.75 . . . . 0.28000000000000003 109.776 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.2 m -117.35 119.38 34.95 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.068 0.461 . . . . 0.34000000000000002 110.116 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.459 ' O ' ' N ' ' A' ' 13' ' ' MET . 76.0 mt -104.24 132.96 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.202 -1.036 . . . . 0.25 108.202 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -147.07 166.48 26.75 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.767 -0.773 . . . . 0.41999999999999998 110.023 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 5.4 ttp -133.06 128.52 36.43 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.175 -0.676 . . . . 1.75 109.175 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -88.01 109.93 20.21 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.156 -0.965 . . . . 1.8400000000000001 108.852 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.7 m -98.8 149.24 35.56 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 108.571 -0.9 . . . . 1.01 108.571 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -72.38 133.5 29.9 Favored 'Cis proline' 0 N--CA 1.501 1.93 0 CA-C-N 120.161 1.093 . . . . 0.81000000000000005 113.514 0.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 62.8 m -106.7 159.99 15.8 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.566 0.698 . . . . 0.59999999999999998 110.109 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -72.4 149.19 44.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.519 -0.738 . . . . 0.67000000000000004 109.705 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.5 -160.14 32.71 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.699 -1.36 . . . . 0.44 109.699 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -95.21 110.46 22.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.464 -1.021 . . . . 2.0299999999999998 109.013 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -54.66 -27.38 39.59 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.351 -0.843 . . . . 2.02 109.107 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.47 -40.33 73.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.101 -0.999 . . . . 0.55000000000000004 109.567 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -72.81 -40.01 66.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.953 -1.092 . . . . 2.1000000000000001 108.844 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.469 ' OD1' HD23 ' A' ' 58' ' ' LEU . 80.5 m-20 -61.15 -39.91 91.85 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.89 -0.782 . . . . 1.27 108.89 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.555 ' CE2' HD11 ' A' ' 102' ' ' LEU . 88.7 t80 -54.64 -42.83 71.74 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.988 -0.745 . . . . 0.39000000000000001 108.988 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -64.5 -39.67 94.22 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.391 -0.818 . . . . 1.8999999999999999 109.142 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.409 ' HA ' HD23 ' A' ' 100' ' ' LEU . 20.5 mt -59.9 -45.09 93.64 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.185 -0.947 . . . . 1.5 109.464 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 96.2 mtp -55.33 -49.93 70.94 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.316 -0.865 . . . . 0.98999999999999999 108.783 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.555 HD11 ' CE2' ' A' ' 98' ' ' PHE . 32.3 mt -62.94 -46.67 86.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.311 -0.868 . . . . 0.34000000000000002 110.07 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.518 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 94.0 mt-30 -59.11 -39.94 83.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.13 -0.982 . . . . 1.8 108.771 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.3 p -71.76 -39.99 69.6 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.138 -0.977 . . . . 0.39000000000000001 109.523 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.0 -56.37 23.1 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.233 -0.917 . . . . 0.31 110.124 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -60.01 -38.14 81.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 1.0700000000000001 109.349 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.518 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 6.9 m-70 -59.95 -48.88 79.88 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.126 -0.984 . . . . 0.47999999999999998 109.119 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.471 HG23 ' OG ' ' A' ' 31' ' ' SER . 77.0 mt -60.59 -49.99 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.35999999999999999 109.274 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.4 -47.11 63.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.492 -0.755 . . . . 0.28999999999999998 109.078 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -61.94 -40.04 94.17 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.414 -0.804 . . . . 1.23 110.161 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -69.97 -40.45 75.37 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.992 -1.068 . . . . 1.8899999999999999 110.983 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.8 m -101.46 7.64 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.505 -0.747 . . . . 0.34999999999999998 109.472 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 61.53 25.54 65.35 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.42 -1.472 . . . . 0.35999999999999999 109.42 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.444 ' O ' ' HB1' ' A' ' 109' ' ' ALA . . . -84.54 -175.05 50.64 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.617 -1.393 . . . . 0.28000000000000003 109.617 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 38.6 t -130.07 138.86 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.816 -0.814 . . . . 0.59999999999999998 109.256 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 22.0 t -76.71 133.31 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.19 -0.944 . . . . 0.33000000000000002 109.589 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 39.7 mt -133.28 162.05 32.84 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.451 0.643 . . . . 0.23999999999999999 109.548 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -89.94 -168.95 2.28 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.513 -0.742 . . . . 1.1299999999999999 109.849 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 88.7 m-20 -59.99 -36.56 77.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.454 -0.779 . . . . 1.1200000000000001 109.146 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -81.14 20.58 0.8 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 1.6899999999999999 109.137 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 33.1 mtt180 52.27 30.5 8.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.513 -0.742 . . . . 2.9399999999999999 110.108 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 -107.87 154.84 20.99 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.697 -0.627 . . . . 3.1299999999999999 109.502 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 91.0 mtp -51.5 121.88 7.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 2.0 109.113 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 17.9 mtp -57.54 137.4 56.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.234 -0.916 . . . . 1.01 109.336 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.9 p -129.95 152.94 80.8 Favored Pre-proline 0 N--CA 1.497 1.888 0 N-CA-C 109.263 -0.643 . . . . 0.56999999999999995 109.263 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -46.19 -43.58 20.76 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 120.855 1.037 . . . . 0.56999999999999995 113.204 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.13 -40.7 90.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.076 -1.015 . . . . 1.79 110.08 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -69.35 -37.1 77.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.051 -1.031 . . . . 1.73 109.686 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 97.5 mt -56.4 -40.07 74.05 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.095 -1.076 . . . . 0.47999999999999998 108.095 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 13.7 mtt-85 -64.67 -38.96 92.8 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.378 -0.827 . . . . 3.77 109.592 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -59.98 -46.83 88.16 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.114 -0.992 . . . . 1.98 109.446 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.424 ' HA ' HD12 ' A' ' 135' ' ' ILE . 60.3 m-85 -60.63 -45.8 92.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.074 -1.016 . . . . 0.40000000000000002 109.695 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -60.11 -36.51 77.63 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.347 -0.846 . . . . 1.5700000000000001 109.108 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.73 -40.06 93.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.201 -0.937 . . . . 1.2 109.721 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 132' ' ' TYR . 56.8 mt -60.94 -41.41 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.072 -1.017 . . . . 0.65000000000000002 108.794 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.7 mt -61.18 -44.38 98.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.338 -0.851 . . . . 0.44 109.622 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -61.94 -48.52 80.04 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.192 -0.943 . . . . 3.02 111.508 -178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.441 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 4.6 mt-10 -60.02 -27.97 67.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.832 -1.168 . . . . 2.29 109.488 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 74.5 t -77.89 -28.21 15.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 120.918 -1.114 . . . . 0.79000000000000004 109.333 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.422 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 28.4 mttm -63.84 -44.87 91.91 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.742 -1.223 . . . . 1.54 110.675 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 141' ' ' ASP . 1.1 p-10 -62.97 -24.0 67.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.069 -1.019 . . . . 1.3999999999999999 109.867 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.36 -34.96 77.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.05 -1.031 . . . . 1.01 108.964 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.49 ' OD1' ' N ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER -107.01 -34.29 7.23 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.615 -0.513 . . . . 2.54 109.615 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.01 -0.995 . . . . 2.4500000000000002 109.426 179.89 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 109.568 -0.53 . . . . 9.0 109.568 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.733 ' N ' ' HZ2' ' A' ' 3' ' ' LYS . 58.6 m-20 -78.91 7.46 7.13 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.652 -1.24 . . . . 6.9199999999999999 107.652 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.733 ' HZ2' ' N ' ' A' ' 2' ' ' ASP . 0.0 OUTLIER -120.4 82.07 31.51 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 106.398 -1.704 . . . . 7.3700000000000001 106.398 177.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.549 ' C ' ' H ' ' A' ' 6' ' ' ARG . 1.9 Cg_endo -64.53 69.15 0.24 Allowed 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 120.895 1.063 . . . . 4.2599999999999998 113.438 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 3' ' ' LYS . 32.3 mttt -68.93 11.96 0.17 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.566 -1.334 . . . . 3.8999999999999999 108.333 178.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.549 ' H ' ' C ' ' A' ' 4' ' ' PRO . 61.6 mtt180 -86.76 141.04 29.15 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.728 -0.841 . . . . 3.1200000000000001 108.728 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -84.44 -0.4 52.7 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.142 -1.059 . . . . 2.2400000000000002 108.142 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -153.65 142.99 21.55 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.081 -1.081 . . . . 2.0499999999999998 108.081 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -161.98 -174.93 4.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.944 -1.098 . . . . 0.46999999999999997 109.946 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 91.7 t -137.95 133.96 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.787 -0.57 . . . . 0.5 109.468 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.4 mm -88.98 132.27 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 107.351 -1.351 . . . . 0.32000000000000001 107.351 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.425 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 85.4 mt -124.05 150.39 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 121.903 0.859 . . . . 0.33000000000000002 110.586 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.459 ' N ' ' O ' ' A' ' 84' ' ' ILE . 37.2 mtt -149.76 157.06 42.85 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.536 -1.283 . . . . 0.54000000000000004 107.536 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -139.98 121.37 15.02 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.25 -0.907 . . . . 1.0900000000000001 111.466 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.9 t -104.28 112.35 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.113 -1.069 . . . . 0.27000000000000002 108.113 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -143.6 156.83 44.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.635 -0.665 . . . . 0.31 109.923 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.47 ' HB2' HD21 ' A' ' 23' ' ' LEU . . . -74.69 -168.91 0.77 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.475 -0.766 . . . . 0.34999999999999998 109.557 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -61.46 164.91 5.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 1.3700000000000001 109.43 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.3 m80 -66.43 146.99 53.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.227 -0.921 . . . . 2.9500000000000002 109.676 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.01 9.95 86.12 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.711 -1.356 . . . . 0.56000000000000005 109.711 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 63.0 m -128.55 144.77 51.21 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.908 -0.76 . . . . 0.45000000000000001 109.165 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -127.51 145.87 50.7 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.395 0.617 . . . . 1.6299999999999999 109.374 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.47 HD21 ' HB2' ' A' ' 17' ' ' ALA . 64.2 mt -85.27 144.35 28.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.337 -0.852 . . . . 0.31 109.373 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -68.07 143.18 55.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.225 -0.922 . . . . 1.0700000000000001 109.153 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.63 -40.0 95.86 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.615 -1.394 . . . . 0.22 109.615 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -62.62 -53.93 47.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.074 -1.25 . . . . 1.79 109.862 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 65.7 mt -63.49 -22.36 66.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.893 . . . . 0.31 109.081 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.613 ' C ' HD23 ' A' ' 28' ' ' LEU . 6.2 tt -75.92 -58.46 3.27 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.439 -0.788 . . . . 0.38 109.066 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.3 mt -60.14 -40.06 88.49 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.275 -0.891 . . . . 0.45000000000000001 110.436 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -62.63 -42.98 99.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.011 -1.056 . . . . 2.21 109.741 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.471 ' OG ' HG23 ' A' ' 108' ' ' ILE . 1.7 p -64.25 -38.89 92.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.2 -0.938 . . . . 1.3700000000000001 109.775 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.5 mt -60.04 -48.82 86.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.877 -1.139 . . . . 0.38 108.749 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -65.03 -41.31 95.37 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.113 -0.992 . . . . 2.1099999999999999 109.997 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -67.71 -15.0 63.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.144 -0.972 . . . . 1.9099999999999999 109.697 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.536 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -83.4 -7.84 59.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.064 -1.022 . . . . 0.44 109.75 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.66 10.36 55.51 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 110.23 -1.148 . . . . 0.35999999999999999 110.23 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -80.49 156.22 26.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.132 -1.216 . . . . 0.57999999999999996 109.726 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 86.5 mt -125.74 136.68 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.907 -0.775 . . . . 0.35999999999999999 108.907 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -59.99 103.83 0.25 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.073 -1.017 . . . . 0.38 109.485 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.31 171.05 34.8 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.337 -1.105 . . . . 0.29999999999999999 110.337 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -64.54 -162.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.591 -0.946 . . . . 1.22 108.929 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 54.81 21.3 3.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.444 -0.785 . . . . 2.1499999999999999 109.158 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.5 m120 50.42 41.4 24.85 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.545 -0.722 . . . . 1.2 111.164 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.8 pt -142.06 164.39 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.16 -0.962 . . . . 0.33000000000000002 108.861 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -91.6 122.27 34.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.125 -0.985 . . . . 0.33000000000000002 110.399 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.519 ' ND1' ' OG ' ' A' ' 60' ' ' SER . 13.8 m-70 -111.49 129.03 56.17 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.565 -0.532 . . . . 1.1399999999999999 109.565 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.536 ' NH1' ' O ' ' A' ' 35' ' ' ALA . 56.2 ttt180 -104.59 128.13 52.5 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.133 -0.692 . . . . 2.0699999999999998 109.133 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.45 ' ND1' ' O ' ' A' ' 55' ' ' GLY . 41.6 m-70 -97.61 171.23 8.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.581 -0.699 . . . . 0.38 109.535 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 62.1 tp -55.6 -50.38 70.29 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.311 -0.868 . . . . 0.54000000000000004 109.025 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.1 m -92.56 145.5 30.59 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.421 -0.799 . . . . 0.60999999999999999 109.507 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -66.44 -5.8 13.63 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 CA-C-N 119.929 1.01 . . . . 0.68000000000000005 112.689 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -91.47 -0.01 57.57 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.098 -1.001 . . . . 2.1899999999999999 109.896 -179.148 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.92 13.67 82.32 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.706 -1.358 . . . . 0.41999999999999998 109.706 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.9 p -72.56 -45.36 59.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.153 -1.204 . . . . 1.4299999999999999 110.384 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.45 ' O ' ' ND1' ' A' ' 48' ' ' HIS . . . -75.98 170.07 54.75 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.706 -1.358 . . . . 0.37 109.706 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -67.88 174.21 8.06 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.067 1.178 . . . . 0.40999999999999998 112.416 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.457 ' C ' HD12 ' A' ' 58' ' ' LEU . . . -83.62 122.68 28.92 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.214 -0.928 . . . . 0.38 109.097 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.701 ' N ' HD12 ' A' ' 58' ' ' LEU . 6.5 mp -96.78 -42.49 7.96 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.276 -0.89 . . . . 0.53000000000000003 109.373 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -145.49 170.34 16.59 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.027 -1.046 . . . . 0.37 108.531 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.519 ' OG ' ' ND1' ' A' ' 46' ' ' HIS . 1.6 m -138.91 179.9 6.22 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.721 -0.792 . . . . 0.53000000000000003 110.738 -177.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.684 HD23 ' C ' ' A' ' 61' ' ' LEU . 6.3 tt -136.57 129.97 31.67 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.914 -0.773 . . . . 0.29999999999999999 108.914 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.565 ' N ' HD23 ' A' ' 61' ' ' LEU . . . -129.13 158.48 38.84 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.3 -0.63 . . . . 0.28000000000000003 109.3 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.413 ' ND2' ' CE2' ' A' ' 70' ' ' PHE . 64.8 m-20 -75.62 158.46 32.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 1.2 109.679 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 90.6 mtp -69.99 -23.02 63.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.396 -0.815 . . . . 1.1699999999999999 109.831 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.69 127.53 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.066 -1.021 . . . . 1.3899999999999999 109.169 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -65.98 150.25 96.79 Favored Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.011 -1.055 . . . . 2.52 109.036 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -76.32 -1.51 22.98 Favored 'Cis proline' 0 N--CA 1.499 1.838 0 C-N-CA 124.196 -1.168 . . . . 0.87 112.994 -0.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.46 16.04 55.95 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.832 -1.175 . . . . 0.47999999999999998 110.233 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.4 p -90.66 167.99 12.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.153 -1.204 . . . . 0.63 110.066 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.413 ' CE2' ' ND2' ' A' ' 63' ' ' ASN . 46.3 m-85 -116.53 157.04 25.88 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.395 -0.965 . . . . 0.51000000000000001 108.395 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.498 ' H ' ' HG3' ' A' ' 74' ' ' MET . 8.7 m-20 -140.36 152.12 65.94 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 109.053 -0.721 . . . . 1.8899999999999999 109.053 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -57.63 -15.66 21.46 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 120.69 0.927 . . . . 0.82999999999999996 113.057 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -88.21 8.62 26.27 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.099 -1.0 . . . . 2.2400000000000002 109.761 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.498 ' HG3' ' H ' ' A' ' 71' ' ' ASP . 1.2 mtm -91.78 22.67 4.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.394 -0.816 . . . . 3.5 110.108 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.412 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 13.2 mttm -83.41 -1.56 53.76 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.031 -1.043 . . . . 1.8200000000000001 108.633 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 75' ' ' LYS . 72.5 m-20 -152.59 73.41 1.02 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.385 -0.822 . . . . 1.4299999999999999 109.364 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -150.21 171.51 16.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.123 -0.986 . . . . 0.42999999999999999 109.007 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 81.4 p -130.28 152.5 49.63 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.223 -0.658 . . . . 0.44 109.223 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.34 149.68 22.02 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.194 -0.941 . . . . 0.22 108.998 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -50.4 -35.99 46.64 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 CA-C-N 119.453 0.84 . . . . 0.29999999999999999 112.232 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 173.39 -151.76 14.24 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.431 -1.468 . . . . 0.23000000000000001 109.431 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 28.6 m -130.57 163.93 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.924 -0.75 . . . . 0.28000000000000003 109.776 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.2 m -117.35 119.38 34.95 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.068 0.461 . . . . 0.34000000000000002 110.116 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.459 ' O ' ' N ' ' A' ' 13' ' ' MET . 76.0 mt -104.24 132.96 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.202 -1.036 . . . . 0.25 108.202 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -147.07 166.48 26.75 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.767 -0.773 . . . . 0.41999999999999998 110.023 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 5.4 ttp -133.06 128.52 36.43 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.175 -0.676 . . . . 1.75 109.175 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -88.01 109.93 20.21 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.156 -0.965 . . . . 1.8400000000000001 108.852 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.7 m -98.8 149.24 35.56 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 108.571 -0.9 . . . . 1.01 108.571 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -72.38 133.5 29.9 Favored 'Cis proline' 0 N--CA 1.501 1.93 0 CA-C-N 120.161 1.093 . . . . 0.81000000000000005 113.514 0.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 62.8 m -106.7 159.99 15.8 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.566 0.698 . . . . 0.59999999999999998 110.109 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -72.4 149.19 44.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.519 -0.738 . . . . 0.67000000000000004 109.705 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.5 -160.14 32.71 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.699 -1.36 . . . . 0.44 109.699 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -95.21 110.46 22.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.464 -1.021 . . . . 2.0299999999999998 109.013 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -54.66 -27.38 39.59 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.351 -0.843 . . . . 2.02 109.107 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.47 -40.33 73.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.101 -0.999 . . . . 0.55000000000000004 109.567 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -72.81 -40.01 66.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.953 -1.092 . . . . 2.1000000000000001 108.844 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.469 ' OD1' HD23 ' A' ' 58' ' ' LEU . 80.5 m-20 -61.15 -39.91 91.85 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.89 -0.782 . . . . 1.27 108.89 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.555 ' CE2' HD11 ' A' ' 102' ' ' LEU . 88.7 t80 -54.64 -42.83 71.74 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.988 -0.745 . . . . 0.39000000000000001 108.988 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -64.5 -39.67 94.22 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.391 -0.818 . . . . 1.8999999999999999 109.142 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.409 ' HA ' HD23 ' A' ' 100' ' ' LEU . 20.5 mt -59.9 -45.09 93.64 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.185 -0.947 . . . . 1.5 109.464 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 96.2 mtp -55.33 -49.93 70.94 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.316 -0.865 . . . . 0.98999999999999999 108.783 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.555 HD11 ' CE2' ' A' ' 98' ' ' PHE . 32.3 mt -62.94 -46.67 86.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.311 -0.868 . . . . 0.34000000000000002 110.07 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.518 ' O ' ' CD2' ' A' ' 107' ' ' HIS . 94.0 mt-30 -59.11 -39.94 83.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.13 -0.982 . . . . 1.8 108.771 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.3 p -71.76 -39.99 69.6 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.138 -0.977 . . . . 0.39000000000000001 109.523 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.0 -56.37 23.1 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.233 -0.917 . . . . 0.31 110.124 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -60.01 -38.14 81.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 1.0700000000000001 109.349 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.518 ' CD2' ' O ' ' A' ' 103' ' ' GLN . 6.9 m-70 -59.95 -48.88 79.88 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.126 -0.984 . . . . 0.47999999999999998 109.119 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.471 HG23 ' OG ' ' A' ' 31' ' ' SER . 77.0 mt -60.59 -49.99 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.35999999999999999 109.274 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 113' ' ' GLY . . . -51.4 -47.11 63.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.492 -0.755 . . . . 0.28999999999999998 109.078 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -61.94 -40.04 94.17 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.414 -0.804 . . . . 1.23 110.161 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -69.97 -40.45 75.37 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.992 -1.068 . . . . 1.8899999999999999 110.983 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.8 m -101.46 7.64 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.505 -0.747 . . . . 0.34999999999999998 109.472 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 109' ' ' ALA . . . 61.53 25.54 65.35 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.42 -1.472 . . . . 0.35999999999999999 109.42 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.444 ' O ' ' HB1' ' A' ' 109' ' ' ALA . . . -84.54 -175.05 50.64 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.617 -1.393 . . . . 0.28000000000000003 109.617 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 38.6 t -130.07 138.86 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.816 -0.814 . . . . 0.59999999999999998 109.256 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 22.0 t -76.71 133.31 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.19 -0.944 . . . . 0.33000000000000002 109.589 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 39.7 mt -133.28 162.05 32.84 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.451 0.643 . . . . 0.23999999999999999 109.548 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.1 p-10 -89.94 -168.95 2.28 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.513 -0.742 . . . . 1.1299999999999999 109.849 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 12' ' ' ILE . 88.7 m-20 -59.99 -36.56 77.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.454 -0.779 . . . . 1.1200000000000001 109.146 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -81.14 20.58 0.8 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 1.6899999999999999 109.137 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 33.1 mtt180 52.27 30.5 8.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.513 -0.742 . . . . 2.9399999999999999 110.108 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 -107.87 154.84 20.99 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.697 -0.627 . . . . 3.1299999999999999 109.502 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 91.0 mtp -51.5 121.88 7.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.378 -0.826 . . . . 2.0 109.113 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 17.9 mtp -57.54 137.4 56.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.234 -0.916 . . . . 1.01 109.336 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.9 p -129.95 152.94 80.8 Favored Pre-proline 0 N--CA 1.497 1.888 0 N-CA-C 109.263 -0.643 . . . . 0.56999999999999995 109.263 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -46.19 -43.58 20.76 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 120.855 1.037 . . . . 0.56999999999999995 113.204 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.13 -40.7 90.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.076 -1.015 . . . . 1.79 110.08 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -69.35 -37.1 77.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.051 -1.031 . . . . 1.73 109.686 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 97.5 mt -56.4 -40.07 74.05 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.095 -1.076 . . . . 0.47999999999999998 108.095 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 13.7 mtt-85 -64.67 -38.96 92.8 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.378 -0.827 . . . . 3.77 109.592 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -59.98 -46.83 88.16 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.114 -0.992 . . . . 1.98 109.446 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.424 ' HA ' HD12 ' A' ' 135' ' ' ILE . 60.3 m-85 -60.63 -45.8 92.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.074 -1.016 . . . . 0.40000000000000002 109.695 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -60.11 -36.51 77.63 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.347 -0.846 . . . . 1.5700000000000001 109.108 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.73 -40.06 93.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.201 -0.937 . . . . 1.2 109.721 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 132' ' ' TYR . 56.8 mt -60.94 -41.41 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.072 -1.017 . . . . 0.65000000000000002 108.794 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.7 mt -61.18 -44.38 98.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.338 -0.851 . . . . 0.44 109.622 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -61.94 -48.52 80.04 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.192 -0.943 . . . . 3.02 111.508 -178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.441 ' O ' ' OD1' ' A' ' 141' ' ' ASP . 4.6 mt-10 -60.02 -27.97 67.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.832 -1.168 . . . . 2.29 109.488 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 74.5 t -77.89 -28.21 15.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 120.918 -1.114 . . . . 0.79000000000000004 109.333 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.422 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 28.4 mttm -63.84 -44.87 91.91 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.742 -1.223 . . . . 1.54 110.675 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 141' ' ' ASP . 1.1 p-10 -62.97 -24.0 67.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.069 -1.019 . . . . 1.3999999999999999 109.867 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.36 -34.96 77.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.05 -1.031 . . . . 1.01 108.964 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.49 ' OD1' ' N ' ' A' ' 143' ' ' ASN . 0.0 OUTLIER -107.01 -34.29 7.23 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.615 -0.513 . . . . 2.54 109.615 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.01 -0.995 . . . . 2.4500000000000002 109.426 179.89 . . . . . . . . 0 0 . 1 stop_ save_